Skip to main content
Clinical Trials/ISRCTN13642102
ISRCTN13642102
Completed
Phase 4

Effect of dexmedetomidine on delirium and postoperative cognitive dysfunction in patients undergoing orthopedic or vascular surgery under regional anesthesia

niversity of Crete0 sites80 target enrollmentApril 27, 2020

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Sedation during regional anaesthesia
Sponsor
niversity of Crete
Enrollment
80
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 27, 2020
End Date
May 10, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Crete

Eligibility Criteria

Inclusion Criteria

  • 1\. Undergoing orthopaedic or vascular surgery under regional anaesthesia
  • 2\. Age \>65 years
  • 3\. Medical history and preoperative anaesthetic assessment to allow regional anesthesia to be used
  • 4\. Must know writing and reading
  • 5\. Remain in the hospital for at least four days
  • 6\. Expected postoperative survival is at least one year (on malignant neoplasms) and with a small chance of re\-operation within three months

Exclusion Criteria

  • 1\. Refuse to receive regional anesthesia or to participate in the study
  • 2\. Central nervous system disease (infectious, metabolic, degenerative, neoplastic, or major psychosis)
  • 3\. Severe vision or hearing impairment
  • 4\. Alcoholics or drug abusers
  • 5\. Severe general condition or in end\-stage neoplasm
  • 6\. Contraindications for regional anaesthesia:
  • 6\.1\. Coagulation disorders:
  • 6\.1\.1\. INR\> 1\.4
  • 6\.1\.2\. Platelet count \<100,000 / µl
  • 6\.1\.3\. Active/uncontrolled bleeding

Outcomes

Primary Outcomes

Not specified

Similar Trials